| Trisha Zylstra, MD | |
|
1471 E Beltline Ave Ne Ste 101, Grand Rapids, MI 49525-4548 | |
| (616) 685-8600 | |
| (616) 365-0057 |
| Full Name | Trisha Zylstra |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 1471 E Beltline Ave Ne Ste 101, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134223779 | NPI | - | NPPES |
| 4927280 | Medicaid | MI | |
| 4927290 | Medicaid | MI | |
| 4927271 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301080272 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health Saint Mary's | Grand rapids, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advantage Health/saint Mary's Medical Group | 4082807961 | 398 |
News Archive
Patients with newly diagnosed pulmonary arterial hypertension have a substantial burden of disease, with more than half hospitalised during the first 3 years post-diagnosis, research shows.
They're two of the biggest mysteries in Parkinson's disease research-where does the disease start? And how can it be stopped early in the process? Now, a new laboratory model of Parkinson's is giving scientists an inside look at what happens in the brain years before motor symptoms appear.
Stanford University officials on Tuesday plan to announce a new policy under which pharmaceutical and medical device companies no longer will have the ability to select continuing medical education courses that they seek to finance for physicians at the university's School of Medicine, the New York Times reports.
The Associated Press: "In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market. … The measure would ban a 'pay-to-delay' practice — opposed by the [Federal Trade Commission] in a series of lawsuits brought since 2001 — in which brand-name drug companies and generic drug makers both profit. Brand-name drug makers get higher prices while the generic companies are paid to stay out of the market."
For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted therapy selpercatinib was well tolerated and achieved durable objective responses, or tumor shrinkage, in the majority of participants in the Phase I/II LIBRETTO-001 trial, according to researchers from The University of Texas MD Anderson Cancer Center.
› Verified 1 days ago
| Entity Name | Advantage Health/saint Mary's Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376862151 PECOS PAC ID: 4082807961 Enrollment ID: O20101023000279 |
News Archive
Patients with newly diagnosed pulmonary arterial hypertension have a substantial burden of disease, with more than half hospitalised during the first 3 years post-diagnosis, research shows.
They're two of the biggest mysteries in Parkinson's disease research-where does the disease start? And how can it be stopped early in the process? Now, a new laboratory model of Parkinson's is giving scientists an inside look at what happens in the brain years before motor symptoms appear.
Stanford University officials on Tuesday plan to announce a new policy under which pharmaceutical and medical device companies no longer will have the ability to select continuing medical education courses that they seek to finance for physicians at the university's School of Medicine, the New York Times reports.
The Associated Press: "In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market. … The measure would ban a 'pay-to-delay' practice — opposed by the [Federal Trade Commission] in a series of lawsuits brought since 2001 — in which brand-name drug companies and generic drug makers both profit. Brand-name drug makers get higher prices while the generic companies are paid to stay out of the market."
For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted therapy selpercatinib was well tolerated and achieved durable objective responses, or tumor shrinkage, in the majority of participants in the Phase I/II LIBRETTO-001 trial, according to researchers from The University of Texas MD Anderson Cancer Center.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trisha Zylstra, MD 1471 E Beltline Ave Ne Ste 101, Grand Rapids, MI 49525-4548 Ph: (616) 685-8600 | Trisha Zylstra, MD 1471 E Beltline Ave Ne Ste 101, Grand Rapids, MI 49525-4548 Ph: (616) 685-8600 |
News Archive
Patients with newly diagnosed pulmonary arterial hypertension have a substantial burden of disease, with more than half hospitalised during the first 3 years post-diagnosis, research shows.
They're two of the biggest mysteries in Parkinson's disease research-where does the disease start? And how can it be stopped early in the process? Now, a new laboratory model of Parkinson's is giving scientists an inside look at what happens in the brain years before motor symptoms appear.
Stanford University officials on Tuesday plan to announce a new policy under which pharmaceutical and medical device companies no longer will have the ability to select continuing medical education courses that they seek to finance for physicians at the university's School of Medicine, the New York Times reports.
The Associated Press: "In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market. … The measure would ban a 'pay-to-delay' practice — opposed by the [Federal Trade Commission] in a series of lawsuits brought since 2001 — in which brand-name drug companies and generic drug makers both profit. Brand-name drug makers get higher prices while the generic companies are paid to stay out of the market."
For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted therapy selpercatinib was well tolerated and achieved durable objective responses, or tumor shrinkage, in the majority of participants in the Phase I/II LIBRETTO-001 trial, according to researchers from The University of Texas MD Anderson Cancer Center.
› Verified 1 days ago
Dr. Marcos Itamar Cordoba Munoz, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 25 Michigan St Ne, Maternal Fetal Medicine Dept, Grand Rapids, MI 49503 Phone: 616-391-3681 | |
Erin Michelle Fricke, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 25 Michigan St Ne Ste 5200, Grand Rapids, MI 49503 Phone: 616-391-3681 | |
Geron D Turke, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1787 Grand Ridge Ct Ne, Suite 201, Grand Rapids, MI 49525 Phone: 616-913-8601 | |
Lisa Anne Andersson-zetye, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2750 E Beltline Ave Ne Fl 1, Grand Rapids, MI 49525 Phone: 616-447-5850 | |
Dr. Andrea C Wolfe, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 329 Saddleback Dr Ne, Grand Rapids, MI 49525 Phone: 616-486-6790 | |
Dr. Mili Thakur, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3230 Eagle Park Dr Ne Ste 100, Grand Rapids, MI 49525 Phone: 616-988-2229 | |
Dr. Gordon Oliver Downey, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 145 Michigan St Ne, Suite 6300, Grand Rapids, MI 49503 Phone: 616-486-6000 Fax: 616-486-2065 |